Back to Journals » Drug Design, Development and Therapy » Volume 2

Review

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease

       
Total article views   HTML views PDF downloads Totals
8,799 Dovepress* 8,799+ 3,188 11,987
Totals 8,799 3,188 11,987
*Since 11 November 2008
+Since July 2016

View citations on Google Scholar